rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
55	aggressive cancer	C2945759	4	67	6.92229829014e-10	2.75e-05	PTGS2,GNA11,TP53,GNAQ
64	Neoplasm of the eye	C0015414	3	40	1.19473868576e-08	3.2e-05	GNA11,TP53,GNAQ
134	Abnormality of the vitreous humor	C4025356	2	26	6.26269171078e-07	6.7e-05	GNA11,GNAQ
135	Cutaneous malignant melanoma 3	C0151779	4	264	6.27593358282e-07	6.75e-05	PTGS2,GNA11,TP53,GNAQ
136	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	C0023485	3	107	6.58059976733e-07	6.800000000000001e-05	PTGS2,GNA15,TP53
137	Retinal detachment	C0035305	3	111	7.62425426903e-07	6.850000000000001e-05	GNA11,TP53,GNAQ
138	Early gastric cancer	C0349530	2	28	7.88429708853e-07	6.900000000000001e-05	PTGS2,TP53
139	Malignant neoplasm of vulva	C0375071	2	28	7.88429708853e-07	6.950000000000001e-05	PTGS2,TP53
140	Squamous cell carcinoma of the hypopharynx	C0280321	2	28	7.88429708853e-07	7.000000000000001e-05	PTGS2,TP53
141	Zonular cataract	C1861821	2	28	7.88429708853e-07	7.049999999999999e-05	GNA11,GNAQ
142	Glaucoma, Open-Angle	C0017612	3	112	7.90355126679e-07	7.099999999999999e-05	PTGS2,TP53,PTGFR
143	Squamous Cell Neoplasms	C0206720	2	29	8.78979700802e-07	7.149999999999999e-05	PTGS2,TP53
144	Chronic atrophic gastritis	C0017154	3	116	9.09717912667e-07	7.2e-05	PTGS2,TP53,GHRL
145	Gastric ulcer	C0038358	3	116	9.09717912667e-07	7.25e-05	PTGS2,TP53,GHRL
146	Thymic Carcinoma	C1322286	2	30	9.76195882352e-07	7.3e-05	PTGS2,TP53
189	keratoacanthoma	C0022572	2	34	1.43651284679e-06	9.45e-05	PTGS2,TP53
190	Pericardial effusion	C0031039	2	34	1.43651284679e-06	9.5e-05	PTGS2,TP53
191	heavy drinking	C0687132	2	35	1.57059914641e-06	9.55e-05	TP53,GHRL
192	Invasive Lobular Breast Carcinoma	C0279565	2	36	1.71261412474e-06	9.6e-05	PTGS2,TP53
193	Ectopia lentis, isolated autosomal recessive	C0013581	2	38	2.02179717201e-06	9.65e-05	GNA11,GNAQ
194	Gastric Cardia Adenocarcinoma	C1333762	2	39	2.18944710595e-06	9.7e-05	PTGS2,TP53
195	Diffuse Astrocytoma	C0280785	2	39	2.18944710595e-06	9.750000000000001e-05	PTGS2,TP53
196	Prostate cancer stage C	C0280280	2	39	2.18944710595e-06	9.800000000000001e-05	PTGS2,TP53
197	Intestinal Cancer	C0346627	2	40	2.36590782365e-06	9.850000000000001e-05	PTGS2,TP53
223	Bronchogenic Carcinoma	C0007121	2	41	2.5517443204e-06	0.0001115	PTGS2,TP53
224	Neoplasm of the tongue	C0040411	2	41	2.5517443204e-06	0.000112	PTGS2,TP53
225	Chemical Carcinogenesis	C0596321	2	42	2.74684465829e-06	0.00011250000000000001	PTGS2,TP53
226	Monosomy	C0026499	3	158	3.12122428825e-06	0.00011300000000000001	GNA11,TP53,GNAQ
227	AIDS Dementia Complex	C0001849	2	44	3.1663246659e-06	0.00011350000000000001	PTGS2,TP53
228	Stomach Diseases	C0038354	2	44	3.1663246659e-06	0.000114	PTGS2,TP53
229	Monocytic leukemia	C0598894	2	44	3.1663246659e-06	0.0001145	PTGS2,TP53
230	Ocular Hypertension	C0028840	2	44	3.1663246659e-06	0.000115	TP53,PTGFR
231	Drug usage	C0242510	2	45	3.39107067049e-06	0.0001155	PTGS2,TP53
232	Capillary hemangiomas	C0206733	2	45	3.39107067049e-06	0.00011600000000000001	TP53,GNAQ
233	Pituitary corticotropic cell adenoma	C1306214	2	45	3.39107067049e-06	0.00011650000000000001	TP53,GHRL
234	CARCINOMA OF VULVA	C0677055	2	46	3.62623573325e-06	0.00011700000000000001	PTGS2,TP53
235	Poorly differentiated carcinoma	C0741899	2	48	4.12828448548e-06	0.0001175	PTGS2,TP53
236	Bile duct cancer resectable	C0740277	2	48	4.12828448548e-06	0.000118	PTGS2,TP53
269	Primary open angle glaucoma juvenile onset 1	C0339573	3	172	4.37209270887e-06	0.00013450000000000002	PTGS2,TP53,PTGFR
270	Pleuritis	C0032231	2	49	4.39572948963e-06	0.000135	PTGS2,TP53
271	Nevus	C0497388	3	174	4.57717582125e-06	0.00013550000000000001	GNA11,TP53,GNAQ
272	Arthritis, Reactive	C0085435	2	50	4.67434425622e-06	0.00013600000000000003	PTGS2,TP53
273	Abnormal pupillary morphology	C0154936	2	51	4.96449010923e-06	0.0001365	GNA11,GNAQ
274	Bloom syndrome	C0005859	2	51	4.96449010923e-06	0.00013700000000000002	PTGS2,TP53
275	Leukoplakia	C0023531	2	52	5.26625012454e-06	0.0001375	PTGS2,TP53
276	Squamous intraepithelial lesion	C0333873	2	52	5.26625012454e-06	0.00013800000000000002	PTGS2,TP53
277	Cervical Adenocarcinoma	C0279672	2	53	5.57993149419e-06	0.0001385	PTGS2,TP53
278	Melanocytic nevus	C0027962	3	185	5.83501495399e-06	0.00013900000000000002	PTGS2,TP53,GNAQ
279	Endometrial Hyperplasia	C0014173	2	54	5.90575138615e-06	0.0001395	PTGS2,TP53
313	Dyspepsia	C0013395	2	56	6.59458966101e-06	0.0001565	PTGS2,TP53
314	Aicardi Goutieres syndrome 1	C0796126	2	56	6.59458966101e-06	0.000157	PTGS2,TP53
315	Arnold-Chiari malformation	C0003803	2	56	6.59458966101e-06	0.0001575	TP53,GNAQ
316	Epilepsy, Temporal Lobe	C0014556	3	192	6.75837142605e-06	0.000158	PTGS2,TP53,GNA14
317	Neoplasm by histology	C4023186	3	193	6.89862024583e-06	0.0001585	GNA11,TP53,GNAQ
318	Medullary carcinoma	C0206693	2	57	6.95815993856e-06	0.00015900000000000002	PTGS2,TP53
319	Malignant Fibrous Histiocytoma	C0334463	2	57	6.95815993856e-06	0.0001595	PTGS2,TP53
320	Oropharyngeal squamous cell carcinoma	C0280313	2	58	7.33460962032e-06	0.00016	PTGS2,TP53
321	Congestive heart failure	C0018802	5	782	7.38825303359e-06	0.0001605	PTGS2,GNA11,TP53,GHRL,GNAQ
322	Oral Submucous Fibrosis	C0029172	2	59	7.72447277031e-06	0.000161	PTGS2,TP53
323	Adenocarcinoma, Endometrioid	C1569637	2	59	7.72447277031e-06	0.0001615	PTGS2,TP53
324	Carcinoma, Lobular	C0206692	2	59	7.72447277031e-06	0.000162	PTGS2,TP53
325	Desmoid tumor	C0079218	2	59	7.72447277031e-06	0.00016250000000000002	PTGS2,TP53
326	Medullary thyroid carcinoma	C0238462	3	201	8.09922281575e-06	0.000163	PTGS2,TP53,GHRL
327	Adverse drug events and drug allergies	C0041755	2	60	8.1276302385e-06	0.00016350000000000002	PTGS2,TP53
328	Pancreatic intraepithelial neoplasia	C1301034	2	61	8.54451901677e-06	0.000164	PTGS2,TP53
329	Malignant neoplasm of the central nervous system	C0348374	2	61	8.54451901677e-06	0.00016450000000000001	PTGS2,TP53
330	Colonic Polyps	C0009376	2	61	8.54451901677e-06	0.000165	PTGS2,TP53
331	Ovarian adenocarcinoma	C0948216	2	61	8.54451901677e-06	0.0001655	PTGS2,TP53
332	Heart Failure	C0018801	5	803	8.59771956285e-06	0.00016600000000000002	PTGS2,GNA15,TP53,GHRL,GNAQ
361	Intraocular melanoma	C0220633	3	206	8.92400701702e-06	0.0001805	GNA11,TP53,GNAQ
362	Turcot syndrome	C0265325	2	62	8.97530791988e-06	0.000181	PTGS2,TP53
363	Esophagitis	C0014868	2	62	8.97530791988e-06	0.0001815	PTGS2,TP53
364	Microsatellite Instability	C0796369	2	63	9.42018478001e-06	0.000182	TP53,GHRL
365	Glaucoma, Angle-Closure	C0017601	4	461	9.58405684359e-06	0.0001825	GNA11,TP53,GNAQ,PTGFR
366	Early-Stage Breast Carcinoma	C2986665	2	64	9.8794519946e-06	0.000183	PTGS2,TP53
367	gliosarcoma	C0206726	2	64	9.8794519946e-06	0.0001835	PTGS2,TP53
368	Ovarian Serous Adenocarcinoma	C1335177	2	64	9.8794519946e-06	0.000184	PTGS2,TP53
369	Breast Fibrocystic Disease	C0016034	2	64	9.8794519946e-06	0.0001845	PTGS2,TP53
370	Angiogenic Switch	C1510885	2	65	1.03532150718e-05	0.000185	PTGS2,TP53
371	Thyroid Nodule	C0040137	2	65	1.03532150718e-05	0.0001855	PTGS2,TP53
372	Overweight	C0497406	3	217	1.09554711587e-05	0.000186	PTGS2,TP53,GHRL
393	Malformation of cortical development	C1955869	2	68	1.18640828602e-05	0.0001965	PTGS2,TP53
394	Malignant neoplasm of colon stage IV	C0278484	2	69	1.23982684069e-05	0.00019700000000000002	PTGS2,TP53
395	Acromegaly	C0001206	2	70	1.29481147289e-05	0.0001975	TP53,GHRL
396	Adenomatous Polyps	C0206677	2	72	1.40955550167e-05	0.00019800000000000002	PTGS2,TP53
397	Uremia	C0041948	2	72	1.40955550167e-05	0.00019850000000000003	TP53,GHRL
398	latent infection	C0872054	2	73	1.4693639771e-05	0.000199	PTGS2,TP53
399	Peutz-Jeghers syndrome	C0031269	2	73	1.4693639771e-05	0.00019950000000000002	PTGS2,TP53
418	Polyposis syndrome, mixed hereditary 1 (4)	C0334108	2	74	1.53082385869e-05	0.00020899999999999998	PTGS2,TP53
419	Granulomatosis with Polyangiitis	C3495801	2	74	1.53082385869e-05	0.0002095	TP53,GHRL
420	Gastritis	C0017152	3	237	1.54977535789e-05	0.00021	PTGS2,TP53,GHRL
421	Oral leukoplakia	C0023532	2	75	1.59394871789e-05	0.0002105	PTGS2,TP53
422	Postoperative Complications	C0032787	2	75	1.59394871789e-05	0.000211	PTGS2,TP53
423	Endometrioma	C0269102	2	75	1.59394871789e-05	0.0002115	PTGS2,TP53
424	Nephrocalcinosis	C0027709	2	76	1.65876429147e-05	0.000212	PTGS2,GNA11
425	Chronic gastritis	C0085695	2	77	1.72531288151e-05	0.0002125	PTGS2,TP53
426	Salivary gland neoplasm	C0036095	2	78	1.79358997913e-05	0.000213	PTGS2,TP53
450	Abnormal thrombosis	C4025731	2	79	1.86362493602e-05	0.00022500000000000002	TP53,GNAQ
451	Rash and Dermatitis Adverse Event Associated with Chemoradiation	C1559154	2	80	1.93543366838e-05	0.0002255	PTGS2,TP53
452	Duodenal Ulcer	C0013295	2	80	1.93543366838e-05	0.00022600000000000002	PTGS2,TP53
453	M5b Acute differentiated monocytic leukemia	C1318544	2	80	1.93543366838e-05	0.0002265	PTGS2,TP53
454	Metaplasia	C0025568	2	80	1.93543366838e-05	0.00022700000000000002	PTGS2,TP53
455	IMMUNE SUPPRESSION	C0021079	2	81	2.00904774339e-05	0.0002275	PTGS2,TP53
456	Stromal Neoplasm	C0879615	2	82	2.08448941835e-05	0.000228	PTGS2,TP53
457	Depressive Disorder	C0011581	4	543	2.11059841415e-05	0.00022850000000000002	PTGS2,TP53,GNB1,GHRL
458	Lichen Planus, Oral	C0206139	2	83	2.16177364885e-05	0.000229	PTGS2,TP53
459	Undifferentiated carcinoma	C0205698	2	83	2.16177364885e-05	0.00022950000000000002	PTGS2,TP53
460	Adult type dermatomyositis	C0221056	2	83	2.16177364885e-05	0.00023	PTGS2,TP53
461	Nasopharyngeal Neoplasms	C0027439	2	84	2.24091805396e-05	0.00023050000000000002	PTGS2,TP53
462	Chronic heart failure	C0264716	2	84	2.24091805396e-05	0.000231	TP53,GHRL
482	Non-Hodgkin lymphoma	C0024305	4	556	2.36448480438e-05	0.000241	PTGS2,GNA15,TP53,GHRL
483	Intervertebral disc degeneration	C0158266	2	86	2.40488442648e-05	0.0002415	PTGS2,GNAQ
484	Cholecystolithiasis	C0947622	2	86	2.40488442648e-05	0.000242	PTGS2,TP53
485	Carcinoid tumor no ICD-O subtype	C0334299	2	87	2.48975356553e-05	0.00024249999999999999	TP53,GHRL
486	Herpes NOS	C0019340	2	87	2.48975356553e-05	0.000243	PTGS2,TP53
487	Tumor Promotion	C1519689	2	88	2.5765700846e-05	0.0002435	PTGS2,TP53
488	Vestibular Schwannoma	C0027859	2	89	2.66535415669e-05	0.000244	PTGS2,TP53
507	High-Grade Prostatic Intraepithelial Neoplasia	C1168327	2	90	2.75613012595e-05	0.0002535	PTGS2,TP53
508	Oral Cavity Carcinoma	C0151546	2	90	2.75613012595e-05	0.000254	PTGS2,TP53
509	Neoplasm by anatomical site	C4023185	4	576	2.80098672732e-05	0.0002545	GNA11,TP53,GNB1,GNAQ
510	Actinic keratosis	C0022602	2	91	2.84891534742e-05	0.000255	PTGS2,TP53
511	Bone neoplasms	C0005967	2	91	2.84891534742e-05	0.00025550000000000003	PTGS2,TP53
512	Pancreatitis	C0030305	3	277	2.8556768659e-05	0.000256	PTGS2,TP53,GHRL
513	Adenocarcinoma, Clear Cell	C0206681	2	94	3.13957260092e-05	0.0002565	PTGS2,TP53
514	Follicular adenoma	C0205647	2	94	3.13957260092e-05	0.000257	PTGS2,TP53
530	Skin carcinoma	C0699893	2	95	3.24061696459e-05	0.00026500000000000004	PTGS2,TP53
531	Oxyphilic Adenoma	C0949541	2	95	3.24061696459e-05	0.0002655	PTGS2,TP53
532	Testicular malignant germ cell tumor	C0855197	2	96	3.34377685414e-05	0.000266	PTGS2,TP53
533	Multiple tumors	C0260037	2	96	3.34377685414e-05	0.0002665	PTGS2,TP53
534	Paresthesia	C0030554	2	97	3.44908698885e-05	0.00026700000000000004	GNA11,TP53
535	Biliary Tract Cancer	C0750952	2	97	3.44908698885e-05	0.0002675	PTGS2,TP53
536	Hyperplastic Polyp	C0333983	2	98	3.55654275132e-05	0.000268	PTGS2,TP53
537	Helicobacter pylori infection	C0850666	3	297	3.74895072481e-05	0.0002685	PTGS2,TP53,GHRL
561	Cystitis	C0010692	2	100	3.7780166804e-05	0.00028050000000000004	PTGS2,TP53
562	Adenocarcinoma Of Esophagus	C0279628	3	300	3.89875541098e-05	0.00028100000000000005	PTGS2,TP53,GHRL
563	Intraocular pressure disorder	C0595921	2	102	4.0083704043e-05	0.00028149999999999996	PTGS2,PTGFR
564	Polymyositis	C0085655	2	102	4.0083704043e-05	0.00028199999999999997	PTGS2,TP53
565	Endometrial adenocarcinoma	C1153706	2	103	4.12692169095e-05	0.0002825	PTGS2,TP53
566	Reperfusion Injury	C0035126	3	305	4.1581188626e-05	0.000283	PTGS2,TP53,GHRL
567	Pain	C0030193	4	628	4.23334673777e-05	0.0002835	PTGS2,GNA11,TP53,GNAQ
589	High grade serous carcinoma	C0206701	2	105	4.3709018595e-05	0.0002945	PTGS2,TP53
590	Rhabdoid Tumor of the Kidney	C0854917	2	105	4.3709018595e-05	0.000295	PTGS2,TP53
591	Neoplasm of the rectum	C0034885	2	105	4.3709018595e-05	0.00029549999999999997	PTGS2,TP53
592	Hamartoma	C0018552	2	106	4.49636358302e-05	0.000296	PTGS2,TP53
593	precancerous lesions	C0940937	2	106	4.49636358302e-05	0.0002965	PTGS2,TP53
594	Neoplasm of the larynx	C0023055	2	106	4.49636358302e-05	0.000297	PTGS2,TP53
595	Neoplasms	C0027651	4	646	4.84333601151e-05	0.00029749999999999997	GNA11,TP53,GNB1,GNAQ
596	Inflammation	C0021368	4	647	4.87911883037e-05	0.000298	PTGS2,TP53,GHRL,PTGFR
597	Mixed Salivary Gland Tumor	C0026277	2	109	4.88688922653e-05	0.0002985	PTGS2,TP53
598	Primary sclerosing cholangitis	C0566602	2	109	4.88688922653e-05	0.000299	PTGS2,TP53
599	Prader-Willi syndrome	C0032897	2	109	4.88688922653e-05	0.0002995	GHRL,GNAQ
600	Abnormal bleeding	C1458140	3	319	4.95171821399e-05	0.0003	GNA11,TP53,GNAQ
621	Huntington's chorea	C0020179	3	320	5.01235083822e-05	0.0003105	PTGS2,TP53,GHRL
622	Helicobacter Infections	C0079487	2	110	5.02183889709e-05	0.000311	PTGS2,TP53
623	Hairy Cell Leukemia	C0023443	2	110	5.02183889709e-05	0.0003115	GNA15,TP53
624	Skin Carcinogenesis	C1519346	2	110	5.02183889709e-05	0.000312	PTGS2,TP53
625	Neoplasm of the adrenal gland	C0001624	2	111	5.15921873714e-05	0.0003125	PTGS2,TP53
626	Von Hippel-Lindau syndrome	C0019562	2	112	5.29904177368e-05	0.000313	PTGS2,TP53
645	Peritonitis	C0031154	2	115	5.73337164844e-05	0.00032250000000000003	PTGS2,TP53
646	Dermatomyositis	C0011633	2	115	5.73337164844e-05	0.000323	PTGS2,TP53
647	Metastatic melanoma	C0278883	3	333	5.85104074544e-05	0.0003235	PTGS2,TP53,GNAQ
648	Nodule	C0028259	2	116	5.88317271429e-05	0.000324	PTGS2,TP53
649	Breast adenocarcinoma	C0858252	2	116	5.88317271429e-05	0.00032450000000000003	PTGS2,TP53
650	Irregular hyperpigmentation	C1860236	2	117	6.03551084344e-05	0.00032500000000000004	GNA11,GNAQ
651	Arrhythmias, Cardiac	C0003811	3	338	6.1994442334e-05	0.0003255	PTGS2,GNA11,GNAQ
662	Hereditary nonpolyposis colorectal cancer type 8	C1333990	2	119	6.34790560986e-05	0.000331	PTGS2,TP53
663	Idiopathic Pulmonary Fibrosis	C1800706	3	341	6.41563558257e-05	0.00033150000000000003	PTGS2,TP53,PTGFR
664	Squamous cell carcinoma of tongue	C0349566	2	120	6.5080083601e-05	0.00033200000000000005	PTGS2,TP53
665	Primary Effusion Lymphoma	C1292753	2	121	6.67072333983e-05	0.0003325	PTGS2,TP53
666	Ependymoma	C0014474	2	121	6.67072333983e-05	0.000333	PTGS2,TP53
667	Erythema	C0041834	2	123	7.00411213109e-05	0.00033350000000000003	PTGS2,TP53
668	Peptic ulcer	C0030920	2	123	7.00411213109e-05	0.00033400000000000004	PTGS2,TP53
669	Telangiectases in sun-exposed and nonexposed skin	C0039446	2	123	7.00411213109e-05	0.00033450000000000005	TP53,GNAQ
698	Hypotension	C0020649	2	129	8.06931821653e-05	0.00034899999999999997	GNA11,GHRL
699	Giant cell arteritis	C0039483	2	129	8.06931821653e-05	0.0003495	PTGS2,TP53
700	Transitional cell carcinoma of the bladder	C0279680	2	132	8.63947003896e-05	0.00035	PTGS2,TP53
701	Intraepithelial Neoplasia	C0878500	2	132	8.63947003896e-05	0.0003505	PTGS2,TP53
702	Musculoskeletal Diseases	C0026857	2	132	8.63947003896e-05	0.00035099999999999997	PTGS2,PTGFR
718	Malignant neoplasm of larynx	C0007107	2	133	8.83521315153e-05	0.000359	PTGS2,TP53
719	Pregnancy Complications, Hematologic	C0032964	2	133	8.83521315153e-05	0.0003595	PTGS2,PTGFR
720	Metastatic malignant neoplasm to brain	C0220650	2	133	8.83521315153e-05	0.00035999999999999997	PTGS2,TP53
721	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	2	134	9.03384428913e-05	0.0003605	PTGS2,TP53
722	Laryngeal Squamous Cell Carcinoma	C0280324	2	134	9.03384428913e-05	0.000361	PTGS2,TP53
723	Anaplastic Oligodendroglioma	C0334590	2	135	9.23536594156e-05	0.0003615	PTGS2,TP53
724	Thyroid Diseases	C0040128	3	376	9.36439225769e-05	0.000362	PTGS2,TP53,GNAQ
725	Basal cell carcinoma	C0007117	2	136	9.43980718061e-05	0.0003625	PTGS2,TP53
726	Leiomyosarcoma	C0023269	2	136	9.43980718061e-05	0.000363	PTGS2,TP53
744	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	3	385	0.000102597469651	0.000372	PTGS2,GNA15,TP53
753	Mammary Tumorigenesis	C1512981	2	141	0.000105064565929	0.0003765	PTGS2,TP53
754	Prostatic Intraepithelial Neoplasias	C0282612	2	142	0.000107288069968	0.000377	PTGS2,TP53
755	Hashimoto thyroiditis	C0677607	2	142	0.000107288069968	0.0003775	PTGS2,TP53
756	Venous thrombosis	C0042487	2	142	0.000107288069968	0.000378	TP53,GNAQ
757	Arterial stenosis	C0038449	2	142	0.000107288069968	0.0003785	PTGS2,TP53
758	Hyperplasia	C0020507	2	143	0.000109542162695	0.000379	PTGS2,TP53
759	Mycosis Fungoides	C0026948	2	143	0.000109542162695	0.0003795	PTGS2,TP53
760	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	C0034069	3	392	0.000109980875847	0.00038	PTGS2,TP53,PTGFR
761	Chronic liver disease	C0341439	2	144	0.000111826958784	0.00038050000000000003	PTGS2,TP53
774	Intestinal Neoplasms	C0021841	2	145	0.000114142581094	0.00038700000000000003	PTGS2,TP53
775	Neoplasm of the central nervous system	C0085136	2	145	0.000114142581094	0.00038750000000000004	PTGS2,TP53
776	Polyglandular Type I Autoimmune Syndrome	C0085859	1	25	0.000123374086897	0.000388	GNA11
777	Lobular carcinoma in situ of breast	C0279563	1	25	0.000123374086897	0.0003885	TP53
778	Pleural Tuberculosis	C0041326	1	25	0.000123374086897	0.000389	TP53
779	Cutaneous lymphoma	C1276146	1	25	0.000123374086897	0.00038950000000000003	TP53
780	Primary malignant neoplasm of liver	C0024620	1	25	0.000123374086897	0.00039000000000000005	TP53
781	Shwachman syndrome	C0272170	1	25	0.000123374086897	0.0003905	TP53
782	Fibromyxosarcoma	C3714524	1	25	0.000123374086897	0.000391	TP53
783	Hyperphosphatemia	C0085681	1	25	0.000123374086897	0.00039150000000000003	GNA11
784	Neoplasms, Radiation-Induced	C0027666	1	25	0.000123374086897	0.00039200000000000004	TP53
785	Post-transplant lymphoproliferative disorder	C0432487	1	25	0.000123374086897	0.0003925	TP53
786	Hearing Loss, Partial	C0018772	2	150	0.000126191285266	0.000393	PTGS2,GNA14
787	Barrett Esophagus	C0004763	2	150	0.000126191285266	0.0003935	PTGS2,TP53
788	invasive cancer	C0677898	2	150	0.000126191285266	0.00039400000000000004	PTGS2,TP53
789	{Aneurysm, familial abdominal 3} (2)	C0002940	2	151	0.000128696324964	0.00039450000000000005	PTGS2,TP53
790	Fetal Diseases	C0015929	2	151	0.000128696324964	0.000395	PTGS2,PTGFR
791	Oropharynx (excludes nasopharynx)	C0521367	1	26	0.000133603091778	0.0003955	TP53
792	Lymphoid hyperplasia	C0333997	1	26	0.000133603091778	0.00039600000000000003	TP53
793	Epidermal cyst	C0014511	1	26	0.000133603091778	0.00039650000000000004	TP53
794	Lafora disease	C0751783	1	26	0.000133603091778	0.00039700000000000005	TP53
795	recurrent childhood acute lymphoblastic leukemia	C0278519	1	26	0.000133603091778	0.0003975	TP53
796	Sarcoma, Epithelioid	C0205944	1	26	0.000133603091778	0.000398	TP53
797	Inappropriate ADH Syndrome	C1332347	1	26	0.000133603091778	0.00039850000000000004	TP53
798	Achalasia	C0014848	1	26	0.000133603091778	0.00039900000000000005	TP53
799	Peritoneal Mesothelioma	C0346109	1	26	0.000133603091778	0.0003995	GNA11
800	Lipomatosis, Multiple	C3489413	1	26	0.000133603091778	0.0004	TP53
801	childhood rhabdomyosarcoma	C0220611	1	26	0.000133603091778	0.00040050000000000003	TP53
802	Malignant neoplasm of adrenal cortex	C0346402	1	26	0.000133603091778	0.00040100000000000004	TP53
803	hemangiopericytoma	C0018922	1	26	0.000133603091778	0.00040150000000000006	TP53
804	Invasive Carcinoma	C1334274	2	154	0.000136405782461	0.000402	PTGS2,TP53
805	Inflammatory abnormality of the eye	C4020969	2	155	0.000139040933211	0.0004025	GNA11,GNAQ
806	androgen independent prostate cancer	C1654637	2	156	0.000141709017637	0.00040300000000000004	PTGS2,TP53
807	Abnormality of the optic disc	C3808249	3	420	0.000143431363708	0.00040350000000000005	GNA11,TP53,GNAQ
808	Cervical dysplasia	C0007868	1	27	0.00014423494667	0.000404	TP53
809	Gallbladder adenocarcinoma	C0279651	1	27	0.00014423494667	0.0004045	TP53
810	Seborrheic keratosis	C0022603	1	27	0.00014423494667	0.00040500000000000003	TP53
811	Bulimia	C0006370	1	27	0.00014423494667	0.00040550000000000004	GHRL
812	Abnormality of male internal genitalia	C4025899	1	27	0.00014423494667	0.00040600000000000006	TP53
813	CHARGE association	C0265354	1	27	0.00014423494667	0.00040649999999999996	TP53
814	Febrile Neutropenia	C0746883	1	27	0.00014423494667	0.00040699999999999997	TP53
815	Treacher Collins syndrome	C0242387	1	27	0.00014423494667	0.0004075	TP53
816	Philadelphia chromosome positive chronic myelogenous leukemia	C0279543	1	27	0.00014423494667	0.000408	TP53
817	Hemangioma	C0018916	2	157	0.000144410269132	0.0004085	TP53,GNAQ
818	Primitive neuroectodermal tumor	C0206663	2	157	0.000144410269132	0.00040899999999999997	PTGS2,TP53
819	Malignant neoplasm of brain and nervous system	C0153633	2	157	0.000144410269132	0.0004095	PTGS2,TP53
820	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	C1847835	2	160	0.000152714963531	0.00041	PTGS2,TP53
821	Liposarcoma, Dedifferentiated	C0205824	1	28	0.0001552693452	0.0004105	TP53
822	Smith-Magenis syndrome	C0795864	1	28	0.0001552693452	0.00041099999999999996	TP53
823	Papillon-Lefevre Disease	C0030360	1	28	0.0001552693452	0.0004115	TP53
824	Astrocytoma, low grade	C1314694	1	28	0.0001552693452	0.000412	TP53
825	Breast cancer recurrent	C0278493	1	28	0.0001552693452	0.0004125	TP53
826	Adenocarcinoma of prostate	C0007112	2	161	0.000155550802755	0.000413	PTGS2,TP53
827	Progressive Neoplastic Disease	C0677932	2	161	0.000155550802755	0.00041349999999999997	PTGS2,TP53
828	Progressive cGVHD	C3539781	2	161	0.000155550802755	0.000414	PTGS2,TP53
829	Disseminated Malignant Neoplasm	C0346957	2	162	0.000158420642995	0.0004145	PTGS2,TP53
830	Albuminuria	C0001925	2	163	0.000161324822064	0.000415	PTGS2,GNAQ
831	Aortic atherosclerosis	C0155733	1	29	0.000166705609878	0.00041549999999999996	PTGS2
832	Dermatofibrosarcoma protuberans	C0392784	1	29	0.000166705609878	0.000416	TP53
833	Pituitary dependent hypercortisolism	C0221406	1	29	0.000166705609878	0.0004165	GHRL
834	Trichothiodystrophy Syndromes	C1955934	1	29	0.000166705609878	0.000417	TP53
835	gastritis h pylori	C0744310	1	29	0.000166705609878	0.0004175	PTGS2
836	Bladder neck obstruction	C0005694	1	29	0.000166705609878	0.00041799999999999997	PTGS2
837	Squamous cell carcinoma of the skin	C0553723	2	166	0.000170244780292	0.0004185	PTGS2,TP53
838	Hemiplegia/hemiparesis	C0375206	2	166	0.000170244780292	0.000419	TP53,GNAQ
839	Encephalitis	C0014038	2	167	0.000173287797219	0.0004195	PTGS2,TP53
840	Malignant neoplasm of gallbladder	C0153452	2	168	0.000176366151053	0.00042	PTGS2,TP53
841	Lymphatic Metastasis	C0024232	2	168	0.000176366151053	0.0004205	PTGS2,TP53
842	Myxoma	C0027149	1	30	0.000178543375188	0.000421	TP53
843	Familial cold-induced inflammatory syndrome 1, 120100 (3)	C0009443	1	30	0.000178543375188	0.0004215	TP53
844	Avellino corneal dystrophy	C1275685	1	30	0.000178543375188	0.000422	TP53
845	T-Cell Prolymphocytic Leukemia	C0023494	1	30	0.000178543375188	0.00042249999999999997	TP53
846	Nodular goiter	C1318500	1	30	0.000178543375188	0.000423	TP53
847	Large cell neuroendocrine carcinoma	C1265996	1	30	0.000178543375188	0.0004235	TP53
848	Verrucae	C0043037	1	30	0.000178543375188	0.000424	TP53
849	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	C1333782	1	30	0.000178543375188	0.0004245	TP53
850	Aortic valve calcification	C0428791	1	30	0.000178543375188	0.000425	PTGS2
851	Tumor necrosis	C0333516	2	170	0.000182628965177	0.0004255	PTGS2,TP53
852	Uterine Cervical Neoplasms	C0007873	2	171	0.000185813914721	0.000426	PTGS2,TP53
853	Cachexia	C0006625	2	171	0.000185813914721	0.0004265	PTGS2,GHRL
854	Cholelithiasis	C0008350	2	171	0.000185813914721	0.000427	PTGS2,TP53
855	Borderline Personality Disorder	C0006012	2	172	0.000189034743522	0.0004275	PTGS2,TP53
856	Gallbladder Diseases	C0016977	1	31	0.000190782252188	0.000428	TP53
857	Creutzfeldt-Jakob Disease, Sporadic	C1852467	1	31	0.000190782252188	0.0004285	PTGS2
858	Neoplasm of the thymus	C3714644	1	31	0.000190782252188	0.000429	TP53
859	Monocytosis	C0085702	1	31	0.000190782252188	0.0004295	TP53
860	Malignant melanoma of eye	C0558356	1	31	0.000190782252188	0.00043	GNAQ
861	Recurrent respiratory papillomatosis	C1168198	1	31	0.000190782252188	0.0004305	TP53
862	Hemiplegia	C0018991	1	31	0.000190782252188	0.000431	GNAQ
863	Lichen Sclerosus et Atrophicus	C0023652	1	31	0.000190782252188	0.0004315	TP53
864	Cytomegalovirus Infections	C0010823	2	174	0.000195584964982	0.000432	PTGS2,TP53
865	Internal hemorrhage	C0333285	2	174	0.000195584964982	0.0004325	GNA11,GNAQ
866	Thymoma	C0040100	2	176	0.000202280954931	0.000433	PTGS2,TP53
867	Epidermolysis bullosa, junctional	C0014527	1	32	0.000203421650601	0.0004335	TP53
868	Hemorrhagic disorder due to intrinsic circulating anticoagulants	C0019087	1	32	0.000203421650601	0.00043400000000000003	GNAQ
869	Gastrinoma	C0017150	1	32	0.000203421650601	0.0004345	TP53
870	Xeroderma Pigmentosum, Complementation Group D	C0268138	1	32	0.000203421650601	0.000435	TP53
871	Hyperpigmentation of the skin	C0162834	2	177	0.000205684144235	0.0004355	GNA11,GNAQ
872	Thyroid cancer, follicular	C0206682	2	177	0.000205684144235	0.000436	PTGS2,TP53
873	Abnormality of the cerebral vasculature	C4022001	2	180	0.000216116334564	0.0004365	TP53,GNAQ
874	Aggressive Non-Hodgkin Lymphoma	C1332225	1	33	0.000216461091064	0.000437	TP53
875	Circumscribed scleroderma	C0036420	1	33	0.000216461091064	0.0004375	TP53
876	Prostate Cancer, Hereditary, 7	C1853195	1	33	0.000216461091064	0.000438	TP53
877	Anterior myocardial infarction	C0340293	1	33	0.000216461091064	0.00043850000000000003	PTGS2
878	Complete hydatidiform mole	C0678213	1	33	0.000216461091064	0.000439	TP53
879	Mucinous Neoplasm	C1334811	1	33	0.000216461091064	0.0004395	PTGS2
880	Follicular neoplasm	C0474808	1	33	0.000216461091064	0.00044	TP53
881	Mucopolysaccharidosis, MPS-IV-B	C0026703	1	33	0.000216461091064	0.00044050000000000003	TP53
882	Prostatitis	C0497496	1	33	0.000216461091064	0.000441	PTGS2
883	Medulloblastoma, Childhood	C0278510	1	33	0.000216461091064	0.0004415	TP53
884	Enzyme inhibition disorder	C0877008	1	33	0.000216461091064	0.000442	PTGS2
885	Recessive dystrophic epidermolysis bullosa	C0079474	1	33	0.000216461091064	0.0004425	TP53
886	Cholangitis	C0008311	1	33	0.000216461091064	0.00044300000000000003	TP53
887	Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	C1332153	1	33	0.000216461091064	0.0004435	TP53
888	Primary Lesion	C1402294	1	33	0.000216461091064	0.000444	TP53
889	Uterine leiomyosarcoma	C0280631	1	33	0.000216461091064	0.0004445	TP53
890	Adenocarcinoma in Situ	C0334276	1	33	0.000216461091064	0.00044500000000000003	TP53
891	Tumor Initiation	C0598935	2	182	0.000223258518601	0.00044550000000000004	PTGS2,TP53
892	Synovial Cyst	C0085648	2	182	0.000223258518601	0.000446	PTGS2,TP53
893	Inflammatory Myofibroblastic Tumor	C0334121	1	34	0.000229900098735	0.0004465	TP53
894	Venous insufficiency	C0042485	1	34	0.000229900098735	0.000447	GNAQ
895	Comedone	C0221228	1	34	0.000229900098735	0.00044750000000000004	TP53
896	Mucosal telangiectasiae	C4022020	1	34	0.000229900098735	0.000448	GNAQ
897	Cushing's syndrome	C0010481	1	34	0.000229900098735	0.0004485	GHRL
898	Malignant neoplasm of oropharynx	C0153382	1	34	0.000229900098735	0.000449	TP53
899	Streptococcal pneumonia	C0155862	1	34	0.000229900098735	0.00044950000000000003	PTGS2
900	Prostate cancer recurrent	C0278838	1	34	0.000229900098735	0.00045000000000000004	TP53
901	Adenoviral infections	C0851887	1	34	0.000229900098735	0.0004505	TP53
902	Therapy-related myelodysplastic syndrome	C1292780	1	34	0.000229900098735	0.000451	TP53
903	 {Nicotine dependence, protection against}, 188890 (3)	C0439857	1	34	0.000229900098735	0.0004515	GHRL
904	Triploidy syndrome	C0333693	1	34	0.000229900098735	0.00045200000000000004	TP53
905	Cervix Diseases	C0007867	1	34	0.000229900098735	0.00045250000000000005	TP53
906	Acinar Cell Carcinoma	C0206685	1	34	0.000229900098735	0.000453	TP53
907	Bisphosphonate-associated osteonecrosis	C2986536	1	34	0.000229900098735	0.0004535	TP53
908	Laryngeal carcinoma	C0595989	2	184	0.000230552186392	0.00045400000000000003	PTGS2,TP53
909	Kaposi's sarcoma	C0036220	2	184	0.000230552186392	0.00045450000000000004	PTGS2,TP53
910	Sensory neuropathy	C0151313	2	185	0.000234256293287	0.000455	GNA11,TP53
911	Status epilepticus	C0038220	2	185	0.000234256293287	0.0004555	PTGS2,TP53
912	Hemianopia	C0018979	1	35	0.000243738312389	0.000456	GNAQ
913	Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	C3536893	1	35	0.000243738312389	0.00045650000000000004	TP53
914	Rhinitis, Allergic, Perennial	C0035457	1	35	0.000243738312389	0.00045700000000000005	PTGS2
915	Asymmetric growth	C4022025	1	35	0.000243738312389	0.0004575	GNAQ
916	childhood brain tumor	C0220603	1	35	0.000243738312389	0.000458	TP53
917	Osteoarthritis of distal interphalangeal joint	C0409957	1	35	0.000243738312389	0.00045850000000000003	PTGS2
918	Endometriosis of ovary	C0156344	1	35	0.000243738312389	0.00045900000000000004	TP53
919	Dermatosis NOS	C0037274	3	483	0.000244937869766	0.00045950000000000006	PTGS2,TP53,PTGFR
920	Abnormality of blood circulation	C4023585	2	189	0.000249458832927	0.00046	GNA11,GNAQ
921	Adenocarcinoma of the large intestine	C1319315	2	189	0.000249458832927	0.0004605	PTGS2,TP53
922	Stomach Neoplasms	C0038356	4	916	0.000250523172032	0.00046100000000000004	PTGS2,TP53,GNA14,GHRL
923	Aortic Aneurysm, Abdominal	C0162871	2	190	0.000253356781342	0.00046150000000000005	PTGS2,TP53
924	Carotid Artery Diseases	C0007273	2	190	0.000253356781342	0.000462	PTGS2,TP53
925	Well Differentiated Oligodendroglioma	C0751396	2	191	0.000257294098914	0.0004625	PTGS2,TP53
926	Fibrosis	C0016059	2	191	0.000257294098914	0.00046300000000000003	PTGS2,TP53
927	Dilated cardiomyopathy 1A	C1449563	2	191	0.000257294098914	0.00046350000000000004	PTGS2,TP53
928	HTLV-I Infections	C0020097	1	36	0.000257975057028	0.00046400000000000006	TP53
929	Buphthalmos	C0020302	1	36	0.000257975057028	0.0004645	GNAQ
930	Metastatic Carcinoma	C1384494	1	36	0.000257975057028	0.000465	TP53
931	Hypoparathyroidism - autosomal dominant	C0342345	1	36	0.000257975057028	0.00046550000000000004	GNA11
932	Churg-Strauss Syndrome	C0008728	1	36	0.000257975057028	0.00046600000000000005	GHRL
933	Benign Ovarian Neoplasm	C0004997	1	36	0.000257975057028	0.0004665	TP53
934	Peptic Ulcer Hemorrhage	C0041582	1	36	0.000257975057028	0.000467	TP53
935	Complete trisomy 18 syndrome	C0152096	1	36	0.000257975057028	0.00046750000000000003	TP53
936	Prolonged bleeding time	C0439590	1	36	0.000257975057028	0.00046800000000000005	TP53
937	Tuberous sclerosis syndrome	C0041341	2	192	0.000261270812626	0.00046850000000000006	PTGS2,TP53
938	Gallbladder Carcinoma	C0235782	2	192	0.000261270812626	0.00046899999999999996	PTGS2,TP53
939	Primary cutaneous marginal zone B-cell lymphoma	C0242647	2	193	0.00026528724319	0.0004695	PTGS2,TP53
940	Neoplasms, Second Primary	C0085183	2	193	0.00026528724319	0.00047	PTGS2,TP53
941	Osteoarthritis of the hand	C0263746	1	37	0.000272610085852	0.0004705	PTGS2
942	Condylomata Acuminata	C0009663	1	37	0.000272610085852	0.000471	TP53
943	Chronic viral hepatitis	C0276623	1	37	0.000272610085852	0.00047149999999999997	TP53
944	Smallpox	C0037354	1	37	0.000272610085852	0.000472	TP53
945	AIDS related complex	C0001857	1	37	0.000272610085852	0.0004725	TP53
946	Sudden death	C0011071	1	37	0.000272610085852	0.000473	PTGS2
947	Spinocerebellar ataxia 7	C0752125	1	37	0.000272610085852	0.00047349999999999996	TP53
948	Acute postoperative pain	C0030201	1	37	0.000272610085852	0.000474	PTGS2
949	Costello syndrome	C0587248	1	37	0.000272610085852	0.0004745	TP53
950	Salmonella infections	C0036117	1	37	0.000272610085852	0.000475	PTGS2
951	Sclerosis	C0036429	1	37	0.000272610085852	0.0004755	PTGS2
952	Mammary adenocarcinoma	C3669246	1	37	0.000272610085852	0.00047599999999999997	TP53
953	Genomic Instability	C0919532	1	37	0.000272610085852	0.0004765	TP53
954	Acute Erythroblastic Leukemia	C0023440	2	195	0.000273439641648	0.000477	PTGS2,TP53
955	Myocardial Reperfusion Injury	C0027055	2	196	0.00027757602644	0.0004775	PTGS2,TP53
956	Papilloma	C0030354	2	196	0.00027757602644	0.00047799999999999996	PTGS2,TP53
957	Connective Tissue Diseases	C0009782	2	196	0.00027757602644	0.0004785	PTGS2,PTGFR
958	Neural tube defect	C0027794	2	196	0.00027757602644	0.000479	TP53,GHRL
959	Chronic hepatitis	C0019189	2	197	0.000281752775187	0.0004795	PTGS2,TP53
960	Chronic colitis	C0267375	1	38	0.000287642696435	0.00048	TP53
961	Xeroderma pigmentosum, group A	C0268135	1	38	0.000287642696435	0.00048049999999999997	PTGS2
962	Lymphosarcoma	C3714542	1	38	0.000287642696435	0.000481	TP53
963	Simple pneumoconiosis	C0032273	1	38	0.000287642696435	0.0004815	PTGS2
964	Chromosome 5, trisomy 5q	C1802398	1	38	0.000287642696435	0.000482	TP53
965	Parathyroid carcinoma	C0687150	1	38	0.000287642696435	0.0004825	TP53
966	Ovarian hyperstimulation syndrome	C0085083	1	38	0.000287642696435	0.000483	PTGS2
967	Abnormality of the optic nerve	C0029131	3	505	0.000290240459462	0.0004835	GNA11,TP53,GNAQ
968	Malignant neoplasm of endometrium	C0007103	3	506	0.000292433448528	0.000484	PTGS2,GNA11,TP53
969	Uterine Corpus Cancer	C0153574	3	506	0.000292433448528	0.0004845	PTGS2,GNA11,TP53
970	Bulimia nervosa 1	C2267227	1	39	0.000303072670114	0.00048499999999999997	GHRL
971	Purpura, Thrombotic Thrombocytopenic	C0034155	1	39	0.000303072670114	0.0004855	PTGS2
972	Rotavirus Infections	C0035869	1	39	0.000303072670114	0.000486	PTGS2
973	Gastro-esophageal reflux disease with esophagitis	C0677659	1	39	0.000303072670114	0.0004865	PTGS2
974	Juvenile polyposis syndrome	C0345893	1	39	0.000303072670114	0.000487	PTGS2
975	Cerebral aneurysm	C0917996	1	39	0.000303072670114	0.0004875	PTGS2
976	Embryonal renal neoplasm	C4023184	1	39	0.000303072670114	0.000488	TP53
977	Intracranial glioma	C3665419	1	39	0.000303072670114	0.0004885	TP53
978	Craniofacial malformations, asymmetric, with polysyndactyly and abnormal skin and gut development	C0376634	2	202	0.000303247491696	0.000489	TP53,GNAQ
979	Death, Sudden, Cardiac	C0011065	2	203	0.000307669941126	0.0004895	PTGS2,TP53
980	Headache	C0018681	2	204	0.000312133826012	0.00049	PTGS2,TP53
981	Arthritis, Psoriatic	C0003872	2	204	0.000312133826012	0.0004905	PTGS2,TP53
982	Transient ischemic attack	C0007787	2	205	0.000316639507945	0.000491	PTGS2,TP53
983	Small Lymphocytic Lymphoma	C0855095	1	40	0.000318899250982	0.0004915	TP53
984	Amaurosis fugax	C0149793	1	40	0.000318899250982	0.000492	TP53
985	Prolymphocytic Leukemia	C0023486	1	40	0.000318899250982	0.0004925	TP53
986	Carcinogenicity	C0858970	1	40	0.000318899250982	0.0004930000000000001	TP53
987	Corneal pannus	C0155094	1	40	0.000318899250982	0.0004935	TP53
988	Netherton syndrome	C0265962	1	40	0.000318899250982	0.000494	PTGS2
989	Neurofibromatoses	C0162678	1	40	0.000318899250982	0.0004945	TP53
990	Stromal sarcoma	C0206630	1	40	0.000318899250982	0.000495	TP53
991	Alcoholic Steatohepatitis	C2718067	1	40	0.000318899250982	0.0004955	TP53
992	Granulomatosis	C0521173	1	40	0.000318899250982	0.000496	TP53
993	Neuropathogenesis	C1518296	1	40	0.000318899250982	0.0004965	PTGS2
994	Mammary Neoplasms, Experimental	C0024668	2	207	0.000325776587052	0.000497	PTGS2,TP53
995	Gastrointestinal carcinoma	C0151544	1	41	0.000335122304396	0.0004975	TP53
996	CNS metastases	C0279130	1	41	0.000335122304396	0.000498	TP53
997	Acute leukemia	C0085669	3	525	0.000336411271129	0.0004985	GNA15,TP53,GNB1
998	Cervical intraepithelial neoplasia (Cervical dysplasia)	C0206708	2	212	0.000349361147554	0.000499	PTGS2,TP53
999	Obesity, Visceral	C2936179	1	42	0.000351741019751	0.0004995	TP53
1000	Primary malignant neoplasm of brain	C0750979	1	42	0.000351741019751	0.0005	TP53
1001	Malignant Conversion	C1518171	1	42	0.000351741019751	0.0005005	TP53
1002	Displacement of intervertebral disc	C0021818	1	42	0.000351741019751	0.000501	PTGS2
1003	Gestational trophoblastic disease	C1135868	1	42	0.000351741019751	0.0005015	TP53
1004	Camptomelic dysplasia	C1861922	1	42	0.000351741019751	0.0005020000000000001	TP53
1005	Carcinosarcoma	C0007140	1	42	0.000351741019751	0.0005024999999999999	TP53
1006	{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	C0206633	1	42	0.000351741019751	0.000503	TP53
1007	Angiofibromas	C0206731	1	42	0.000351741019751	0.0005034999999999999	TP53
1008	Benign neoplasm of other endocrine glands	C0086692	2	213	0.00035420654872	0.000504	PTGS2,TP53
1009	Anaphylactic shock NOS	C0002792	1	43	0.000368755118059	0.0005045	PTGS2
1010	Chronic interstitial cystitis	C0600040	1	43	0.000368755118059	0.000505	TP53
1011	Cholesteatoma	C0008373	1	43	0.000368755118059	0.0005055	TP53
1012	Malignant neoplasm of male breast	C0242787	1	43	0.000368755118059	0.000506	TP53
1013	Dryness of eye	C0314719	1	43	0.000368755118059	0.0005065	PTGS2
1014	Leukemia, Plasma Cell	C0023484	1	43	0.000368755118059	0.000507	TP53
1015	Ovarian epithelial cancer stage III	C0280220	1	43	0.000368755118059	0.0005074999999999999	TP53
1016	Meningioma, benign, no ICD-O subtype	C1762616	2	217	0.000374022244666	0.000508	PTGS2,TP53
1017	Epstein-Barr Virus Infections	C0149678	2	219	0.000384192876794	0.0005085	PTGS2,TP53
1018	Primary Carcinoma	C1335475	1	44	0.000386164132657	0.000509	TP53
1019	Cervical intraepithelial neoplasia grade 1	C0349458	1	44	0.000386164132657	0.0005095	TP53
1020	Precursor cell lymphoblastic lymphoma	C0079748	1	44	0.000386164132657	0.00051	TP53
1021	Cystadenoma	C0010633	1	44	0.000386164132657	0.0005105	TP53
1022	Single tumor	C1298180	1	44	0.000386164132657	0.0005110000000000001	TP53
1023	Skin cancer	C0007114	2	222	0.000399780816619	0.0005115	PTGS2,TP53
1024	Chondrosarcoma	C0008479	2	222	0.000399780816619	0.000512	PTGS2,TP53
1025	Benign neoplasm of the central nervous system	C0347509	1	45	0.000403967502897	0.0005124999999999999	TP53
1026	Ganglioglioma	C0206716	1	45	0.000403967502897	0.000513	TP53
1027	Thromboangiitis Obliterans	C0040021	1	45	0.000403967502897	0.0005135	PTGS2
1028	Yolk Sac Tumor	C0014145	1	45	0.000403967502897	0.000514	TP53
1029	Acute intermittent porphyria	C0162565	1	45	0.000403967502897	0.0005145	TP53
1030	Varicose Ulcer	C0042344	1	45	0.000403967502897	0.000515	TP53
1031	Bone necrosis	C0029445	1	45	0.000403967502897	0.0005155	TP53
1032	Age-related cataract	C0036646	1	45	0.000403967502897	0.0005160000000000001	TP53
1033	Fuchs' Endothelial Dystrophy	C0016781	1	45	0.000403967502897	0.0005164999999999999	TP53
1034	Mammary Carcinoma, Human	C1257930	1	45	0.000403967502897	0.000517	TP53
1035	Oropharyngeal disorders	C0553694	1	45	0.000403967502897	0.0005175	TP53
1036	Hereditary cutaneous melanoma	C1512419	1	45	0.000403967502897	0.000518	TP53
1037	Ductal Carcinoma	C1527349	2	223	0.000405066041772	0.0005185	PTGS2,TP53
1038	Metastatic Prostate Carcinoma	C0936223	2	224	0.000410396117301	0.000519	PTGS2,TP53
1039	{Unipolar depression, susceptibility to}, 608516 (3)	C0011570	3	555	0.000415277068213	0.0005195	PTGS2,TP53,GHRL
1040	Neoplasm of the oral cavity	C0026640	2	226	0.000421191677197	0.0005200000000000001	PTGS2,TP53
1041	Adenosquamous carcinoma	C0206623	1	46	0.000422164902833	0.0005205	TP53
1042	Dry Eye Syndromes	C0013238	1	46	0.000422164902833	0.000521	PTGS2
1043	Chronic Fatigue Syndrome	C0015674	1	46	0.000422164902833	0.0005214999999999999	PTGS2
1044	Neoplasm of the respiratory system	C0035244	1	46	0.000422164902833	0.000522	TP53
1045	Photoparoxysmal response 1 (2)	C1868677	1	46	0.000422164902833	0.0005225	TP53
1046	Drusen	C1260959	1	47	0.00044075571776	0.000523	PTGS2
1047	Agranulocytosis	C0001824	1	47	0.00044075571776	0.0005235	TP53
1048	Isochromosomes	C0242621	1	47	0.00044075571776	0.000524	TP53
1049	Li-Fraumeni syndrome	C0085390	1	47	0.00044075571776	0.0005245	TP53
1050	Melanocytic nevus of skin	C3665593	1	47	0.00044075571776	0.0005250000000000001	TP53
1051	Nijmegen Breakage Syndrome	C0398791	1	47	0.00044075571776	0.0005254999999999999	TP53
1052	Metastatic Renal Cell Cancer	C0278678	1	47	0.00044075571776	0.000526	TP53
1053	Trisomy 12	C0432408	1	47	0.00044075571776	0.0005265	TP53
1054	Invasive Ductal Breast Carcinoma	C1134719	2	231	0.00044897751425	0.000527	PTGS2,TP53
1055	Pelvic inflammatory disease	C0242172	1	48	0.000459739474458	0.0005275	PTGS2
1056	Dyskeratosis congenita, autosomal dominant 6	C0265965	1	48	0.000459739474458	0.000528	TP53
1057	Renovascular hypertension	C0020545	1	48	0.000459739474458	0.0005285	PTGS2
1058	Macrocytic anemia	C0002886	1	48	0.000459739474458	0.0005290000000000001	TP53
1059	Neck Neoplasms	C0027533	1	48	0.000459739474458	0.0005295	TP53
1060	Squamous cell carcinoma of mouth	C0585362	1	48	0.000459739474458	0.0005300000000000001	TP53
1061	Carcinoma, Papillary	C0007133	2	233	0.00046041407582	0.0005304999999999999	PTGS2,TP53
1062	Parkinsonism	C0242422	2	233	0.00046041407582	0.000531	PTGS2,TP53
1063	Constitutional symptom	C0009812	3	572	0.000465441369008	0.0005315	GNA11,TP53,GNAQ
1064	Nasal polyposis	C0027430	2	236	0.000477918165808	0.000532	PTGS2,TP53
1065	Ovarian Diseases	C0029928	2	236	0.000477918165808	0.0005325	GHRL,GNAQ
1066	Ganglioneuroblastoma	C0206718	1	49	0.000479115819914	0.000533	TP53
1067	Neoplasm of the gallbladder	C0016978	1	49	0.000479115819914	0.0005335	TP53
1068	Splenic Marginal Zone B-Cell Lymphoma	C0349632	1	49	0.000479115819914	0.0005340000000000001	TP53
1069	Friedreich's ataxia	C0016719	1	49	0.000479115819914	0.0005345	PTGS2
1070	Exostoses	C0015302	1	49	0.000479115819914	0.000535	GNAQ
1071	Airway Obstruction	C0001883	1	49	0.000479115819914	0.0005355	PTGFR
1072	Coronary Restenosis	C0948480	1	49	0.000479115819914	0.000536	TP53
1073	Cervical intraepithelial neoplasia grade 2	C0349459	1	49	0.000479115819914	0.0005365	TP53
1074	Hepatocellular adenoma	C0206669	1	49	0.000479115819914	0.000537	TP53
1075	Papillomavirus Infections	C0950124	1	49	0.000479115819914	0.0005375	TP53
1076	Bronchopulmonary Dysplasia	C0006287	2	237	0.000483846667884	0.0005380000000000001	PTGS2,TP53
1077	Dermal atrophy	C0151514	2	237	0.000483846667884	0.0005385	PTGS2,TP53
1078	Abnormal inflammatory response	C4022805	3	581	0.000493690087856	0.0005390000000000001	GNA11,TP53,GNAQ
1079	Increased inflammatory response	C4022803	3	581	0.000493690087856	0.0005394999999999999	GNA11,TP53,GNAQ
1080	Hematocrit level	C0518014	1	50	0.000498884170725	0.00054	PTGS2
1081	Idiopathic fibrosing alveolitis, chronic form	C0085786	1	50	0.000498884170725	0.0005405	PTGS2
1082	Vascular lesions	C1402315	1	50	0.000498884170725	0.000541	TP53
1083	stage, non-small cell lung cancer	C0280217	1	50	0.000498884170725	0.0005415	TP53
1084	Neuritis	C0027813	1	50	0.000498884170725	0.0005420000000000001	PTGS2
1085	Malignant neoplasm of tongue	C0153349	1	50	0.000498884170725	0.0005425	TP53
1086	Adenocarcinoma of colon	C0338106	2	240	0.000501915601052	0.0005430000000000001	PTGS2,TP53
1087	Vitiligo	C0042900	2	241	0.000508033697409	0.0005435	PTGS2,TP53
1088	Abnormal peripheral nervous system morphology	C4025831	3	587	0.000513192457628	0.0005440000000000001	GNA11,TP53,GNAQ
1089	Malignant neoplasm of female breast	C0235653	1	51	0.000519044196348	0.0005445	TP53
1090	Abnormal synaptic transmission	C4021083	1	51	0.000519044196348	0.000545	GNA11
1091	Hypocalcemia	C0020598	1	51	0.000519044196348	0.0005455	GNA11
1092	Uterine Cancer	C0153567	1	51	0.000519044196348	0.000546	PTGS2
1093	Abnormal peripheral nervous system synaptic transmission	C4021046	1	51	0.000519044196348	0.0005465	GNA11
1094	Hereditary breast and ovarian cancer syndrome	C0677776	1	51	0.000519044196348	0.0005470000000000001	TP53
1095	Acute respiratory failure	C0264490	1	51	0.000519044196348	0.0005475	TP53
1096	Phyllodes tumor, benign	C0010701	1	51	0.000519044196348	0.0005480000000000001	TP53
1097	Abnormal synaptic transmission at the neuromuscular junction	C4025618	1	51	0.000519044196348	0.0005485	GNA11
1098	Neoplasm of the skeletal system	C2732838	1	52	0.000539595288853	0.000549	TP53
1099	Nervous tissue neoplasm	C0027665	1	52	0.000539595288853	0.0005495	TP53
1100	Hyperostosis	C0020492	1	52	0.000539595288853	0.00055	GNAQ
1101	Abnormality of phosphate homeostasis	C4022032	1	52	0.000539595288853	0.0005505	GNA11
1102	Meningeal Neoplasms	C0025284	1	52	0.000539595288853	0.0005510000000000001	TP53
1103	Peptic Esophagitis	C0014869	1	52	0.000539595288853	0.0005515	PTGS2
1104	Lehman syndrome	C1851710	1	52	0.000539595288853	0.0005520000000000001	TP53
1105	Abnormality of urine calcium concentration	C4023434	1	52	0.000539595288853	0.0005525	GNA11
